Movement Alert｜Recursion Pharmaceuticals, Inc. Intraday Rise 8.13% in Regular Trading, Webinar Set to Highlight Updated REC-4881 Data

Market Focus10-28 00:27

On October 28, Recursion Pharmaceuticals, Inc. rose 8.13% in Regular Trading, trading at $4.105 per share, with turnover of $43.9039 million.

The move followed the company’s announcement that it will host a November 3 webinar focused on updated REC-4881 data from CGA-IGC, alongside business updates, key opinion leader commentary, and patient discussions.

Additional context shows the company recently disclosed that Sanofi selected the first drug candidate from their collaboration, triggering a $10 million milestone payment. Recursion Pharmaceuticals, Inc. said upfront and milestone payments under that partnership have reached $144 million, with eligibility for more than $300 million in additional milestones plus double-digit royalties on net sales if approved. The webinar timing is also notable because the company’s next earnings release is scheduled for November 2.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment